Viewing Study NCT06181734


Ignite Creation Date: 2025-12-25 @ 2:21 AM
Ignite Modification Date: 2025-12-27 @ 7:02 AM
Study NCT ID: NCT06181734
Status: COMPLETED
Last Update Posted: 2025-12-09
First Post: 2023-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ivosidenib (TIBSOVO®) Combined With Azacitidine According to Current SmPC
Sponsor: iOMEDICO AG
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module